64 related articles for article (PubMed ID: 24492945)
1. Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
Mehta A; Mavromatis K; Ko YA; Rogers SC; Dhindsa DS; Goodwin C; Patel R; Martini MA; Prasad M; Mokhtari A; Hesaroieh IG; Frohwein SC; Kutner MH; Harzand A; Wells BJ; Duwayri Y; Alabi O; Rajani RR; Brewster LP; Waller EK; Quyyumi AA
Contemp Clin Trials; 2020 Apr; 91():105975. PubMed ID: 32145440
[TBL] [Abstract][Full Text] [Related]
2. The relationship between weight loss and health-related quality of life in persons treated for head and neck cancer.
Head BA; Heitz L; Keeney C; Myers J; Appana SN; Studts JL; Bumpous J; Pfeifer M
Support Care Cancer; 2011 Oct; 19(10):1511-8. PubMed ID: 20730547
[TBL] [Abstract][Full Text] [Related]
3. The impact of pretreatment symptom burden on long-term quality of life following head and neck radiation: A prospective longitudinal study.
Ladbury C; Wilde T; Amini A; Xiao Y; Maghami E; Massarelli E; Vora N; Sun V; Sampath S
Head Neck; 2024 May; ():. PubMed ID: 38817083
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human epidermal growth factor on neuropathic pain associated with radiotherapy for head and neck malignancies and nursing strategy.
Hong Y; Cheng Z; Xu L; Tang Q; Gao J
Int J Neurosci; 2024 Apr; ():1-7. PubMed ID: 38512026
[TBL] [Abstract][Full Text] [Related]
5. Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.
Macann A; Fua T; Milross CG; Porceddu SV; Penniment M; Wratten C; Krawitz H; Poulsen M; Tang CI; Morton RP; Hay KD; Thomson V; Bell ML; King MT; Fraser-Browne CL; Hockey HU
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):572-9. PubMed ID: 24521675
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy-Specific Chronic Pain Syndromes in the Cancer Population: An Evidence-Based Narrative Review.
Karri J; Lachman L; Hanania A; Marathe A; Singh M; Zacharias N; Orhurhu V; Gulati A; Abd-Elsayed A
Adv Ther; 2021 Mar; 38(3):1425-1446. PubMed ID: 33570737
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation.
Krčálová E; Horáček J; Gabalec F; Žák P; Doležal J
Eur J Oral Sci; 2020 Jun; 128(3):204-210. PubMed ID: 32239618
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines.
Logan RM; Al-Azri AR; Bossi P; Stringer AM; Joy JK; Soga Y; Ranna V; Vaddi A; Raber-Durlacher JE; Lalla RV; Cheng KKF; Elad S;
Support Care Cancer; 2020 May; 28(5):2485-2498. PubMed ID: 32080767
[TBL] [Abstract][Full Text] [Related]
9. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology).
Siano M; Dulguerov P; Broglie MA; Henke G; Putora PM; Simon C; Zwahlen D; Huber GF; Ballerini G; Beffa L; Giger R; Rothschild S; Negri SV; Elicin O
Front Oncol; 2019; 9():1127. PubMed ID: 31709187
[No Abstract] [Full Text] [Related]
10. Potential Therapeutic Effects of Gut Hormones, Ghrelin and Obestatin in Oral Mucositis.
Stempniewicz A; Ceranowicz P; Warzecha Z
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934722
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
[TBL] [Abstract][Full Text] [Related]
12. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.
Pugh SL; Wyatt G; Wong RK; Sagar SM; Yueh B; Singh AK; Yao M; Nguyen-Tan PF; Yom SS; Cardinale FS; Sultanem K; Hodson DI; Krempl GA; Chavez A; Yeh AM; Bruner DW
J Pain Symptom Manage; 2017 Jan; 53(1):139-145.e2. PubMed ID: 27899312
[TBL] [Abstract][Full Text] [Related]
13. Emerging targets for radioprotection and radiosensitization in radiotherapy.
Kumar S; Singh RK; Meena R
Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
[TBL] [Abstract][Full Text] [Related]
14. Xerostomia health-related quality of life: NRG oncology RTOG 0537.
Wyatt G; Pugh SL; Wong RK; Sagar S; Singh AK; Koyfman SA; Nguyen-Tân PF; Yom SS; Cardinale FS; Sultanem K; Hodson I; Krempl GA; Lukaszczyk B; Yeh AM; Berk L
Qual Life Res; 2016 Sep; 25(9):2323-33. PubMed ID: 26914104
[TBL] [Abstract][Full Text] [Related]
15. Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.
Aro K; Bäck L; Loimu V; Saarilahti K; Rogers S; Sintonen H; Roine R; Mäkitie A
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2141-50. PubMed ID: 26216625
[TBL] [Abstract][Full Text] [Related]
16. Radiation induced oral mucositis: a review of current literature on prevention and management.
Mallick S; Benson R; Rath GK
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2285-93. PubMed ID: 26116012
[TBL] [Abstract][Full Text] [Related]
17. Oral epithelial stem cells - implications in normal development and cancer metastasis.
Papagerakis S; Pannone G; Zheng L; About I; Taqi N; Nguyen NP; Matossian M; McAlpin B; Santoro A; McHugh J; Prince ME; Papagerakis P
Exp Cell Res; 2014 Jul; 325(2):111-29. PubMed ID: 24803391
[TBL] [Abstract][Full Text] [Related]
18. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE; Pugh SL; James JL; Scarantino C; Movsas B; Valicenti RK; Fortin A; Pollock J; Kim H; Brachman DG; Berk LB; Bruner DW; Kachnic LA
Qual Life Res; 2014 Aug; 23(6):1841-58. PubMed ID: 24492945
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
